Peer-reviewedCC BYDiagnostics (Basel, Switzerland)
Stemness-Associated Biomarkers in Breast Cancer Liver Metastasis: Hepatic Adaptation, Prognostic Relevance, and Monitoring
- 1Graduate School, Guizhou Medical University, Guiyang 550004, China
- 2Department of Breast Surgery, Guizhou Provincial People’s Hospital, Guiyang 550002, China
Related
- Blood-based inflammatory biomarkers in ovarian cancer: addressing the challenge of early detection, metastasis, and prognostic stratification.
- Identification of hepatitis B virus-associated membrane proteins as prognostic biomarkers for hepatocellular carcinoma based on retrospective analysis of integrated membrane proteomics
- Transcriptomic profiling reveals autophagy-associated programs and prognostic biomarkers in anoikis-resistant pancreatic cancer cells.
- Prognostic factors in thyroid cancer with lung-only metastasis: SEER-based retrospective study
- Clinical outcomes and prognostic factors of Ommaya reservoir-based intrathecal chemotherapy in lung cancer leptomeningeal metastasis: a retrospective cohort study
BibTeX
@article{hu2026stemnessassociated,
title = {{Stemness-Associated Biomarkers in Breast Cancer Liver Metastasis: Hepatic Adaptation, Prognostic Relevance, and Monitoring}},
author = {Bin Hu and Jing Hou and Shihang Hu},
journal = {Diagnostics (Basel, Switzerland)},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13664281},
note = {CC BY},
}
RIS
TY - JOUR
TI - Stemness-Associated Biomarkers in Breast Cancer Liver Metastasis: Hepatic Adaptation, Prognostic Relevance, and Monitoring
AU - Bin Hu
AU - Jing Hou
AU - Shihang Hu
PY - 2026
DA - 2026/09/22
JO - Diagnostics (Basel, Switzerland)
UR - https://europepmc.org/article/PMC/PMC13664281
SN - 2075-4418
ER -